NAD+ 1G & RETATRUTIDE - A UK UPDATE

NAD+ 1g & Retatrutide - A UK Update

The growing landscape of metabolic support in the UK is seeing significant interest in the combination of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1000mg – and the novel GLP-1 receptor agonist Retatrutide (or its analogue Tirzepatide). Specialists are observing poten

read more


Emerging Weight Reduction Hope?

Retatrutide is attracting considerable interest as a innovative treatment for weight issues . This groundbreaking medication, developed by the company , represents a major advance in weight control therapies. It works by acting like two gut hormones, GLP-1 and GIP, which affect appetite and

read more